prediabetes glp 1 GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Tirzepatide Cuts Risk of Diabetes
Description
Plans should take into account the likelihood of approval if non-formulary, considering the limited alternative options for this indication and mechanism of action
The region boasts numerous peptide CMOs and a well-established regulatory framework
Theres something for everyone
Tirzepatide was approved under the brand name Mounjaro for T2D in May 2022
Initial consultation fees can vary, and some platforms, like LillyDirect, require a one-time onboarding fee
Wall M, George D
